Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Yкраїнський (UK)
Przejdź do strony domowej biblioteki Centralna Biblioteka Wojskowa Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaCentralna Biblioteka Wojskowa

Wyszukujesz frazę "Hepatitis B" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-10 z 39
Tytuł:
Antiviral drug resistance rates among patients with chronic hepatitis B infection
Autorzy:
Özlük, Suat
Bayram, Yasemin
Özkaçmaz, Ayşe
Parlak, Mehmet
Özdemir, Ayşe
Aypak, Cenk
Powiązania:
https://bibliotekanauki.pl/articles/25102375.pdf
Data publikacji:
2023-06-30
Wydawca:
Uniwersytet Rzeszowski. Wydawnictwo Uniwersytetu Rzeszowskiego
Tematy:
antiviral agents
antiviral drug resistance
chronic hepatitis B
hepatitis B
Opis:
Introduction and aim. Chronic hepatitis B infection (CHB) affects millions of people around the world. Many clinicians find it challenging to choose therapeutic agents due to the mutations that occur in the hepatitis B virus (HBV) that cause drug resistance. Thus, the aim of this study was to determine the HBV resistance rates against the currently recommended first-line therapies in the region of our country where HBV prevalence is high. Material and methods. A total of 96 patients (56 men and 40 women) with HBV infection were enrolled in the study. The serum samples collected from those were analyzed with real-time polymerase chain reaction analysis followed by pyrosequencing (PyroStar HBV Drug Resistance Test, Altona Diagnostics, Germany) for drug resistance mutations associated with lamivudine, adefovir, telbivudine, entecavir, and tenofovir. Results. HBV drug-resistance mutations were investigated in 80 treatment-naïve and 16 treatment-experienced patients (6 entecavir, 4 PEGylated-interferon, 4 tenofovir, 2 lamivudine). None of the HBV-DNA samples had mutations cause to drug resistance were detected in any codons regions that were analyzed. Conclusion. Antiviral resistance poses serious obstacles for clinicians in the treatment of CHB. Determining whether antiviral resistance exists in HBV is critical to choose the appropriate treatment agent.
Źródło:
European Journal of Clinical and Experimental Medicine; 2023, 2; 283-288
2544-2406
2544-1361
Pojawia się w:
European Journal of Clinical and Experimental Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Hepatitis B and C infection: Is it a problem in Polish healthcare workers?
Autorzy:
Rybacki, Marcin
Piekarska, Anna
Wiszniewska, Marta
Walusiak-Skorupa, Jolanta
Powiązania:
https://bibliotekanauki.pl/articles/2179151.pdf
Data publikacji:
2013-06-01
Wydawca:
Instytut Medycyny Pracy im. prof. dra Jerzego Nofera w Łodzi
Tematy:
healthcare workers
HBV prevalence
HCV prevalence
hepatitis B vaccination
ALT testing
Opis:
Objectives: Hepatitis B (HBV) and C viruses (HCV) are among the most frequent blood borne pathogens. According to WHO, 5% of healthcare workers (in central Europe), are exposed to at least one sharps injury contaminated with HBV per year, 1,7% - contaminated with HCV. Aims: The aims of the study were to determine prevalence of HCV and HBV infections, vaccination efficacy against hepatitis B and usefulness of alanine aminotransferase (ALT) testing in prophylactic examinations in healthcare workers (HCWs). Material and Methods: In a group of 520 healthcare workers, a survey, laboratory and serologic tests such as ALT, HBsAg, anti-HBs, anti-HBcT and anti-HCV were carried out. Results: The study revealed a low rate of workers with presence of HBsAg and anti-HCV (1,2% and 0,8% respectively). Anti-HBcT was found in 99 subjects (19%) without a significant association with experiencing an occupational percutaneous injury. Being vaccinated against HBV was declared by 90% of the subjects. There was no relationship between ALT level rise and positive HBsAg, anti-HCV and anti-HBcT tests. Conclusion: A seroprevalence of HBV and HCV markers in HCWs found in the study is low and similar to the one found in general population. Current or past hepatitis B infections were independent of needle stick injuries. Vaccination against HBV coverage, although found to be high, should improve to 100%. Occupational prophylactic medical examinations found performing ALT test (obligatory in Poland for HCWs) not helpful. It seems that determination of anti-HBcT and anti-HCV status would be essential in pre-employment medical examinations.
Źródło:
International Journal of Occupational Medicine and Environmental Health; 2013, 26, 3; 430-439
1232-1087
1896-494X
Pojawia się w:
International Journal of Occupational Medicine and Environmental Health
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Hepatic expression of miR-122 and antioxidant genes in patients with chronic hepatitis B
Autorzy:
Wójcik, Kamila
Piekarska, Anna
Szymańska, Bożena
Jabłonowska, Elżbieta
Powiązania:
https://bibliotekanauki.pl/articles/1038774.pdf
Data publikacji:
2016
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
hepatitis B
antioxidant genes
miR-122
Opis:
Introduction: The pathogenesis of chronic hepatitis B depends on both, the immune response and oxidative stress. Aim of the study: To assess the hepatic expression of miR-122 and the antioxidant genes: HMOX-1, NQO1 and GFER1, in liver biopsy specimens obtained from patients with chronic hepatitis B, with regard to selected clinical and histological parameters, using RT-PCR. Results: The study group comprised 34 HBV-infected patients. Statistically significant associations were found between lower hepatic expression of HMOX-1 and greater severity of liver inflammation (p=0.04). However, significantly higher expression of NQO1 was observed in patients with advanced liver fibrosis (p=0.035). Hepatic expression of miR-122 in HBV patients was not associated with viral load or liver injury. Conclusion: The hepatic expression of HMOX-1and NQO1 may be associated with liver injuries in chronic hepatitis B. However, hepatic expression of miR-122 does not seem to correspond to progression of the liver disease.
Źródło:
Acta Biochimica Polonica; 2016, 63, 3; 527-531
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Virological response to treatment with peginterferon alfa-2a in adolescents with chronic hepatitis B
Autorzy:
Pawlowska, Małgorzata
Halota, Waldemar
Kozielewicz, Dorota
Jendryczka, Ewa
Powiązania:
https://bibliotekanauki.pl/articles/1039657.pdf
Data publikacji:
2012
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
peginterferon alfa-2a
thrombocytopenia
hepatitis B virus
chronic hepatitis B
Opis:
Background: There are few data on the efficacy and safety of pegylated interferon treatment in adolescents with chronic hepatitis B. Aim: We conducted a pilot study in 13 adolescents with chronic hepatitis B treated with peginterferon alfa-2a at 100 µg/m2 once weekly for 48 weeks. Methods: HBV DNA was assessed by qPCR method. Results: After four weeks of treatment six adolescents had undetectable HBV DNA (<12 IU/mL). Seven adolescents - including five HBV negatives at week 4 - had undetectable HBV DNA (<55 IU/mL) at week 24, and seven adolescents - including all HBV DNA negatives at week 4 - had undetectable HBV DNA at week 48 of treatment (<55 IU/mL). Five adolescents had undetectable HBV DNA (<55 IU/mL) after 24 weeks of follow-up (sustained viral response). HBeAg seroconversion was achieved in one patient. HBsAg loss was documented at the end of therapy in two of the six adolescents HBV DNA negative at week 4 of treatment. Three adolescents withdrew from the treatment (two because of adverse events, one because of withdrawal of parental consent). Leukopenia was reported in seven adolescents and three individuals experienced thrombocytopenia. Except for one patient who discontinued treatment due to leukopenia, no dose modifications for adverse events or laboratory abnormalities were required. Conclusion: This pilot study shows that 48 weeks of treatment with peginterferon alfa-2a can result in sustained HBV DNA suppression, HBeAg seroconversion and HBsAg loss in adolescents with CHB. Larger and longer trials are now required to better define the magnitude of the benefit in this group of patients.
Źródło:
Acta Biochimica Polonica; 2012, 59, 4; 587-591
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The seroprevalence of the hepatitis B virus in Italian medical students after 3 decades since the introduction of universal vaccination
Autorzy:
Sartorelli, Pietro
Occhialini, Federico
Miceli, Rosalia
Pietronigro, Antonella
Bianciardi, Laura
Salini, Chiara
Messina, Gabriele
Powiązania:
https://bibliotekanauki.pl/articles/2085658.pdf
Data publikacji:
2022-02-15
Wydawca:
Instytut Medycyny Pracy im. prof. dra Jerzego Nofera w Łodzi
Tematy:
hepatitis B
vaccination
medical students
immunization
hepatitis B antibodies
seroepidemiological studies
Opis:
ObjectivesSince 1991 hepatitis B vaccination has been mandatory for all newborns in Italy. The aim of the study was to verify the long-term seroprevalence and the efficacy of hepatitis B vaccination in medical students of the University of Siena.Material and MethodsA cross-sectional observational study was conducted on a population of 850 medical students of the University of Siena (322 males and 528 females, mean age: 23 years) by obtaining from the medical reports the serological analysis data for the total anti-hepatitis B antibodies (HBsAb) and information on hepatitis B vaccination (number of vaccine doses, age at the first vaccination, time since the final vaccination dose, country of origin). Raw odds ratios (ORs) and 95% confidence intervals (CIs) were initially calculated to evaluate the association between 2 variables. The adjusted ORs were then calculated using a multivariate logistic regression model to study the association between the variables and the possible confounding factors.ResultsOverall, 593 students (69.76%) were immunized against hepatitis B, while 257 (30.24%) had HBsAb antibody titer <10 mIU/ml. From the OR calculation, an inverse correlation emerged between seropositivity to hepatitis B and age, and between seropositivity to hepatitis B and the age at the first vaccination dose. There was also a correlation between seropositivity and the number of vaccination doses received. By performing the multivariate logistic analysis, correlations with these variables were confirmed.ConclusionsA significant part of the studied population was not immunized against hepatitis B virus, despite the fact that vaccination had been carried out as prescribed by law. The results of the study reaffirm the importance of health surveillance in subjects at biological risk such as medical students.
Źródło:
International Journal of Occupational Medicine and Environmental Health; 2022, 35, 1; 75-80
1232-1087
1896-494X
Pojawia się w:
International Journal of Occupational Medicine and Environmental Health
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Czynniki dobrej odpowiedzi na leczenie przeciwwirusowe zakażenia HBV
Factors that predict response to hepatitis B treatment
Autorzy:
Janocha-Litwin, Justyna
Simon, Krzysztof
Powiązania:
https://bibliotekanauki.pl/articles/552866.pdf
Data publikacji:
2014
Wydawca:
Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
Tematy:
hepatitis B
predictors of response
treatment
interferon alpha
nucleo-ti(-si)de analogues
Opis:
Duża liczba osób zakażonych wirusem zapalenia wątroby typu B na świecie i w Polsce oraz ograniczona dostępność i skuteczność leczenia przyczynowego wymusza poznanie czynników odpowiedzi na stosowaną terapię. Ma to na celu wybranie jak najlepszego leku oraz możliwość modyfikacji leczenia w trakcie terapii. W pracy omówiono poznane czynniki/znaczniki odpowiedzi na leczenie zakażenia HBV. Czynnikami dobrej odpowiedzi na terapię PEG-IFN wyjściowo są: niska wiremia HBV DNA , obecność HBeAg, wysoka aktywność Al at, genotyp A lub B HBV oraz wysoka aktywność zapalna w badaniu histopatologicznym bioptatu wątroby. Monitorowanie skuteczności leczenia przeciwwirusowego oceną wiremii HBV DNA metodą PCR , ilościowego oznaczania HBsAg, HBeAg i kinetyki spadku tych stężeń umożliwia modyfikację leczenia w trakcie jego trwania. Dalej istnieje potrzeba selekcjonowania nowych czynników pozwalających przewidywać skuteczność prowadzonego leczenia przeciwwirusowego u zakażonych HBV w celu ograniczenia ryzyka rozwoju odległych powikłań, tj. rozwoju marskości wątroby ze wszystkimi następstwami, oraz raka wątrobowokomórkowego
A large number of people infected with hepatitis B virus in Poland and the world as well as limited availability and efficiency of causal therapy necessitate further research on predictors of response to the therapy. It has to provide choosing the best medication and capability to modify the therapy. The paper discusses predictors of responses to the HBV therapy. Factors associated with response to PEG-IFN therapy are: low HBV DNA level, HBeAg presence, high Al at activity and active inflammation in histopathological examination of the liver biopsy. Modification of the therapy is possible by monitoring its effectiveness by using the assessment of HBV DNA levels with PCR method, HBsAg quantification and kinetics of the decrease in their concentrations. There is still a need to discover new factors that will let predict the efficiency of the antiviral therapy in HBV positive patients to decrease the risk of developing the long-term complications such as liver cirrhosis and hepatocellular cancer
Źródło:
Family Medicine & Primary Care Review; 2014, 1; 44-47
1734-3402
Pojawia się w:
Family Medicine & Primary Care Review
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Expression of hepatitis B core antigen in lettuce and tobacco for advanced plant-derived vaccine formulations
Autorzy:
Pyrski, M.
Kasprzyk, A.
Bogusiewicz, M.
Bociag, P.
Czyz, M.
Pniewski, T.
Powiązania:
https://bibliotekanauki.pl/articles/951208.pdf
Data publikacji:
2015
Wydawca:
Polska Akademia Nauk. Czytelnia Czasopism PAN
Tematy:
conference
hepatitis B virus
antigen expression
virus-like particle
transgenic tobacco
lettuce plant
Agrobacterium tumefaciens
immunoblot
ELISA test
Źródło:
BioTechnologia. Journal of Biotechnology Computational Biology and Bionanotechnology; 2015, 96, 1
0860-7796
Pojawia się w:
BioTechnologia. Journal of Biotechnology Computational Biology and Bionanotechnology
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Construction and expression of indonesian hepatitis B core antigen (HBcAg) in Lactococcus lactis as potential therapeutic vaccine
Autorzy:
Anwar, R.I.
Mustopa, A.Z.
Ningrum, R.A.
Sucharsono, S.
Powiązania:
https://bibliotekanauki.pl/articles/81249.pdf
Data publikacji:
2019
Wydawca:
Polska Akademia Nauk. Czytelnia Czasopism PAN
Tematy:
hepatitis B virus
antigen
Lactococcus lactis
cytotoxic T
immune response
therapeutic vaccination
protein expression
patient
Indonesia
Źródło:
BioTechnologia. Journal of Biotechnology Computational Biology and Bionanotechnology; 2019, 100, 1
0860-7796
Pojawia się w:
BioTechnologia. Journal of Biotechnology Computational Biology and Bionanotechnology
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Seroprevalence of hepatitis B and C viruses: Awareness and safe practices of hairdressers in Izmir — A survey
Autorzy:
Kose, Şukran
Mandiracioglu, Aliye
Oral, Ahmet M.
Emek, Mestan
Gozaydin, Ayhan
Kuzucu, Lutfiye
Turken, Melda
Powiązania:
https://bibliotekanauki.pl/articles/2185385.pdf
Data publikacji:
2011-09-01
Wydawca:
Instytut Medycyny Pracy im. prof. dra Jerzego Nofera w Łodzi
Tematy:
knowledge
attitudes
blood-borne infections
hairdresser
barber
seroprevalance
Opis:
Objectives: The aim of the study is to determine the seroprevalence of hepatitis B (HBV) and hepatitis C virus (HCV) infection in barbers and to assess the awareness of these employees related to occupational risks of HBV and HCV. Materials and Methods: In this study, 2145 barbers in Izmir were given an occupational safety seminar. Blood samples were collected from 2066 voluntary participants and 1284 individuals completed the questionnaires. Sera were tested for the presence of HBV and HCV markers by ELISA. Results: Our results document low levels of knowledge about HBV and HCV infection, risk perception and adequate protection among participants before the seminar session. Of the participants, 63.5% reported that they had suffered from equipment-related injuries during the last month. The prevalence of HBsAg positive and anti-HCV individuals of the 2066 person was found to be 2.2% and 0.4%, respectively. Conclusions: Hairdressers’ knowledge of HBV, HCV and health hazards associated with their profession was inadequate. The prevalence of HBsAg positive and anti-HCV was similar to that among the general population.
Źródło:
International Journal of Occupational Medicine and Environmental Health; 2011, 24, 3; 275-282
1232-1087
1896-494X
Pojawia się w:
International Journal of Occupational Medicine and Environmental Health
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Prevalence of hepatitis B virus infection among barbers and their knowledge, attitude and practices in the district of Sukkur, Sindh
Autorzy:
Abbasi, Imran N.
Fatmi, Zafar
Kadir, Muhammad M.
Sathiakumar, Nalini
Powiązania:
https://bibliotekanauki.pl/articles/2178888.pdf
Data publikacji:
2014-10-01
Wydawca:
Instytut Medycyny Pracy im. prof. dra Jerzego Nofera w Łodzi
Tematy:
hepatitis B
barbers
peri-urban
Sukkur
knowledge
attitude and practices
Opis:
Objectives: Several occupations in developing countries lag behind in ensuring the safety of their workers in occupational settings. Lack of implementation of safety guidelines at workplaces can expose workers to health risks. In Pakistan, barbers are one of the un-regulated occupational groups. Low literacy, increased frequency of direct skin contact and blade/razors use can expose barbers to body fluids including blood of the customers. We conducted this study in order to determine hepatitis B virus (HBV) prevalence among barbers and their knowledge, attitude and practices in a peri-urban district of Sindh. Material and Methods: Three hundred eighty-five barbers from the Sukkur district were interviewed using a structured questionnaire. Blood samples were collected and tested for HBsAg. A scale was built to determine the proportions of responses to knowledge, attitude and practice items. Results: The prevalence of HBV among barbers was 2.1%. The barbers’ knowledge on HBV and its transmission routes was poor. The response to attitude items was good, except that only 35.1% of the participants agreed to have vaccination against HBV. The overall performance on the knowledge and practice scales was poor compared to the attitude scale on which 80% of the barbers performed well. Conclusion: The prevalence of HBV among barbers was lower compared to the available national figures for the prevalence among the general population.
Źródło:
International Journal of Occupational Medicine and Environmental Health; 2014, 27, 5; 757-765
1232-1087
1896-494X
Pojawia się w:
International Journal of Occupational Medicine and Environmental Health
Dostawca treści:
Biblioteka Nauki
Artykuł
Wyświetlanie 1-10 z 39

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies